XORTX Therapeutics Statistics

Total Valuation

XRTX has a market cap or net worth of $3.80 million. The enterprise value is $1.70 million.

Market Cap	3.80M
Enterprise Value	1.70M

Important Dates

The last earnings date was Friday, November 15, 2024.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

XRTX has 3.48 million shares outstanding. The number of shares has increased by 36.17% in one year.

Current Share Class	3.48M
Shares Outstanding	3.48M
Shares Change (YoY)	+36.17%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	1.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.22, with a Debt / Equity ratio of 0.03.

Current Ratio	6.22
Quick Ratio	5.97
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -17.92% and return on invested capital (ROIC) is -42.68%.

Return on Equity (ROE)	-17.92%
Return on Assets (ROA)	-33.81%
Return on Capital (ROIC)	-42.68%
Revenue Per Employee	n/a
Profits Per Employee	-$245,552
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.87% in the last 52 weeks. The beta is -0.21, so XRTX's price volatility has been lower than the market average.

Beta (5Y)	-0.21
52-Week Price Change	-55.87%
50-Day Moving Average	1.38
200-Day Moving Average	2.14
Relative Strength Index (RSI)	36.92
Average Volume (20 Days)	16,985

Short Selling Information

The latest short interest is 2,642, so 0.08% of the outstanding shares have been sold short.

Short Interest	2,642
Short Previous Month	3,740
Short % of Shares Out	0.08%
Short % of Float	0.08%
Short Ratio (days to cover)	0.02

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.84M
Pretax Income	-3.34M
Net Income	-736,657
EBITDA	-2.85M
EBIT	-2.84M
Earnings Per Share (EPS)	-$0.29

Full Income Statement

Balance Sheet

The company has $2.30 million in cash and $61,468 in debt, giving a net cash position of $2.24 million or $0.64 per share.

Cash & Cash Equivalents	2.30M
Total Debt	61,468
Net Cash	2.24M
Net Cash Per Share	$0.64
Equity (Book Value)	2.13M
Book Value Per Share	0.73
Working Capital	2.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$4.09 million and capital expenditures -$1, giving a free cash flow of -$4.09 million.

Operating Cash Flow	-4.09M
Capital Expenditures	-1
Free Cash Flow	-4.09M
FCF Per Share	-$1.17

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.17%
Shareholder Yield	-36.17%
Earnings Yield	-19.37%
FCF Yield	-107.56%

Analyst Forecast

The average price target for XRTX is $14.00, which is 1,184.40% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	1,184.40%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 14, 2023. It was a reverse split with a ratio of 0.1111111:1.

Last Split Date	Nov 14, 2023
Split Type	Reverse
Split Ratio	0.1111111:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a